Search
Showing search results forBryan Bryson: Engineering solutions to the tough problem of tuberculosis
On his desk, Bryan Bryson ’07, PhD ’13 still has the notes he used for the talk he gave at MIT when he interviewed for a faculty position in biological…
Eighteen MIT faculty honored as “Committed to Caring” for 2025-27
At MIT, a strong spirit of mentorship shapes how students learn, collaborate, and imagine the future. In a time of accelerating change — from breakthroughs in artificial intelligence to…
Sean Luk: Addressing the urgent need for better immunotherapy
In elementary school, Sean Luk loved donning an oversized lab coat and helping her mom pipette chemicals at Johns Hopkins University. A few years later, she started a science blog…
New study suggests a way to rejuvenate the immune system
As people age, their immune system function declines. T cell populations become smaller and can’t react to pathogens as quickly, making people more susceptible to a variety of infections. To…
A new immunotherapy approach could work for many types of cancer
Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make cancer immunotherapy work for…
MIT HEALS leadership charts a bold path for convergence in health and life sciences
In February, President Sally Kornbluth announced the appointment of Professor Angela Koehler as faculty director of the MIT Health and Life Sciences Collaborative (MIT HEALS), with professors Iain Cheeseman…
A better DNA material for genetic medicine
To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That’s because most genetic medicine uses viruses or double-stranded DNA to deliver genetic…
MIT researchers find new immunotherapeutic targets for glioblastoma
Glioblastoma is the most common form of brain cancer in adults, and its consequences are usually quick and fatal. After receiving standard-of-care treatment (surgery followed by radiation and…